[Regulation]Regulation update: EU REACH Annex XVII amendment (Apr. 2, 2025)

29 Jun 2025

On April 2, 2025, the European Commission (EC) issued Regulation (EU) 2025/660, an amending adding a new entry 50a (PAHs) to the REACH Annex XVII list.

  • Publication in the EU Official Journal (EU 2025/660): April 2, 2025

  • Date of entry into force: Aril 22, 2025


Regulation overview

  • EU REACH (Registration, Evaluation, Authorization and Restriction of Chemicals, EC 1907/2006) is the EU’s comprehensive regulatory framework for the management of chemical substances, covering registration, evaluation, authorization, and restriction.

  • When a substance is identified as posing a risk to human health or the environment, EU Member States or the European Chemicals Agency (ECHA) may submit a restriction proposal.

  • Following public consultations and opinion development by expert committees, ECHA submits a recommendation to the European Commission.

  • If the recommendation is accepted, it is published in the EU Official Journal (OJ) and enters into legal force.

bddac7c7a7bab.png


ECHA Restriction Process


Key Changes

  • Addition of Entry 50a (PAHs) to Annex XVII of EU REACH

  • Substance Details

    • PAHs are present in raw materials used for the manufacture of clay targets for shooting (e.g., CTPHT – coal tar pitch, high temperature)

    • PAHs possess carcinogenic, persistent, bio-accumulative and toxic (PBT), and very persistent and very bio-accumulative (vPvB) properties

    • Entry 50a specifies 18 CAS numbers

7e6c59a6b3794.png



MDSKorea Inc. 

Head Office: 314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

Seoul Office: Digital-ro 26-gil, Guro-gu, Seoul, Korea 

Incheon Office : 22, Inha-ro 489-beon-gil, Namdong-gu, Incheon, Korea 


Copyright ⓒ 2026 MDSKorea Inc. All Rights Reserved

Business Registration No.: 142-81-81626 | E-commerce Registration No.: 2024-YonginSuji-1885 

Representative: Yongyeon Hwang


Request a Consultation

Have questions about our services? 

Submit your inquiry, and our team will get back to you promptly.

MDSKorea Inc.

  Head Office

314, Gwanggyojungang-ro, Suji-gu, Yongin-si, Gyeonggi-do, Korea

  Seoul Office

173, Digital-ro, Geumcheon-gu, Seoul, Korea 

  Incheon Office

22, Inha-ro 489beon-gil, Namdong-gu, Incheon, Korea 

ⓒ 2023 MDSKorea Inc. All Rights Reserved